Epilepsy, Absence: Clinical Trials

1 trial for Epilepsy, Absence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Epilepsy, Absence: new trials by email Literature Review of Epilepsy, Absence trials Research Report on Epilepsy, Absence

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
BHV-7000, Placebo - Generalized Epilepsy
Phase 2 / Phase 3TerminatedBiohaven Therapeutics Ltd.272024-06-202026-03-24

Narrower conditions

Drug Resistant Epilepsy (1)  ·  Epilepsy (1)  ·  Epilepsy, Generalized (1)  ·  Epilepsy, Idiopathic Generalized (1)  ·  Myoclonic Epilepsy, Juvenile (1)  ·  Seizures (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Epilepsies, Myoclonic (1)  ·  Epileptic Syndromes (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Sponsors

Biohaven Therapeutics Ltd. (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Croatia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Portugal (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2023 (1)